Leonard Schleifer’s profile picture

Leonard Schleifer

CEO and Founder, Regeneron Pharmaceuticals
Leonard Schleifer’s profile picture
Net worth 2018: $1.24 Billion
Industry: Healthcare
Residence: Tarrytown, New York
Country: United States
BirthDay: 1953
Children: 3
Education: Bachelor of Arts / Science, Cornell University; Medical Doctor, University of Virginia; Ph.D, University of Virginia
BIOGRAPHY

Leonard Schleifer was bornon 1953 in Tarrytown, New York, United States, is CEO and Founder, Regeneron Pharmaceuticals. Leonard Schleifer is #1747 in List Billionaires People In The World. Leonard Schleifer cofounded drugmaker Regeneron in 1988. He remains CEO of the Tarrytown, New York company, which has been looking for a follow-up to Eylea, a treatment for macular degeneration with more than $5 billion in sales. Their big hope, cholesterol drug Praluent, has had disappointing sales and faces a patent infringement case from rival Amgen. Regeneron is now betting on a treatment for atopic dermatitis to be a big hit. Schleifer, who has most of his fortune tied up in Regeneron, grew up in Queens. He was the son of a sweater manufacturer who attended Cornell on scholarship and dreamed of a medical career but had to return to the family business. Schleifer followed his father's footsteps to Cornell and then got an M.D.-PhD degree at the University of Virginia, training with future Nobel Laureate Alfred Gilman. Regeneron now sponsors the Science Talent Search competition for high school students. It was previously run by Westinghouse, then, more recently, Intel. Schleifer competed as a teenager.

NET WORTH STATISTIC
2014

$1 Billion

2015

$1.8 Billion

2016

$1.3 Billion

2017

$1.4 Billion

2018

$1.24 Billion

TIMELINE
2015

According to the "annual collaborative report" from Equilar and The New York Times, Schleifer ranked 15th in the May 2015 list of "200 highest-paid CEOs of large publicly traded companies

2014

As CEO Schleifer received a total compensation of $41,965,424 in 2014

2011

" In 2011, Regereron's first successful drug was, Eylea, for age-related macular degeneration

1988

He also recruited George Yancopoulos, a 28-year-old scientist, to be his partner, and in 1988 they founded Regeneron Pharmaceuticals

1953

Schleifer (born 1953) is the founder and chief executive of the biotechnology company Regeneron

(4.9/135 votes)
Related Person
Otto Philipp Braun’s profile picture
Otto Philipp Braun
Net Worth is $4.06 Billion
B.R. Shetty’s profile picture
B.R. Shetty
Net Worth is $4.04 Billion
Traudl Engelhorn’s profile picture
Traudl Engelhorn
Net Worth is $4 Billion
Christoph Zeller’s profile picture
Christoph Zeller
Net Worth is $3.92 Billion
Xu Jingren’s profile picture
Xu Jingren
Net Worth is $3.62 Billion
Kiran Mazumdar-Shaw’s profile picture
Kiran Mazumdar-Shaw
Net Worth is $3.54 Billion